This website isn’t supported by Internet Explorer. We recommend that you use a different browser (e.g. Edge, Chrome, Firefox, Safari, or similar) for the best experience of our content.
/ / /
/ / /

For healthcare professionals only

You are viewing the Novo Nordisk Virtual platform, provided to non-US health care professionals from around the world. By accessing this site and materials you accept this legal notice and expressly confirm your status as a healthcare professional.

 

This site is not country-specific and therefore may contain information which is not applicable to your country. Therefore, before prescribing any product, always refer to local materials such as the prescribing information and/or the Summary of Product Characteristics.

 

This site is not intended to provide medical advice and/or treatment guidance. Novo Nordisk accepts no liability for the accuracy, completeness or use of the information, and disclaims any liability to update the information contained on this site.

I hereby declare I am a non-US health care professional and that I have read and agreed to the terms mentioned above.

Scroll down

Rethink Obesity

Connecting medical professionals with useful tools to manage obesity effectively.
Rethink Obesity Adolescents

Addressing obesity for the next generation.
Action Teens

ACTION teens is a global, cross-sectional survey aimed at identifying perceptions, attitudes, behaviours, and barriers to effective obesity care among adolescents living with obesity, their caregivers, and healthcare professionals. Findings from this study reveal a misalignment between these three groups and demonstrate the urgent need for better information and communication across the board. The study also supports a need for improved HCP training, to help treat and prevent obesity in adolescents.4
Action Teens

ACTION teens is a global, cross-sectional survey aimed at identifying perceptions, attitudes, behaviours, and barriers to effective obesity care among adolescents living with obesity, their caregivers, and healthcare professionals. Findings from this study reveal a misalignment between these three groups and demonstrate the urgent need for better information and communication across the board. The study also supports a need for improved HCP training, to help treat and prevent obesity in adolescents.4

From May 11-14 2025, Malaga, Spain, sets the stage for the 32nd European Congress on Obesity (ECO2025). The ECO congress provides an opportunity to delve into the latest breakthroughs within the field of obesity science and weight management. The congress is a platform for engagement with peers from the global obesity community fostering discussions and exploration of the most recent advancements in obesity research and clinical practice. The ECO2025 congress is hosted by The European Association for the Study of Obesity (EASO). Established in 1986, EASO is a leading voice of obesity research and medical management of obesity in Europe.

1.

Wegovy® [summary of product characteristics]. Bagsværd, Denmark: Novo Nordisk A/S; July 2024.

2.

Garvey WT, Batterham RL, Bhatta M, et al. Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nat Med. 2022;28(10):2083-2091.

3.

Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019. Update From the GBD 2019 Study. J Am Coll Cardiol. 2020 Dec.76(25)2982–3021. Doi: 10.1016/j.jacc.2020.11.010.

4.

Halford JCG, et al. Misalignment among adolescents living with obesity, caregivers, and healthcare professionals: ACTION Teens global survey study. Pediatric Obesity.2022;17:e12957. Available at: https://onlinelibrary.wiley.com/doi/10.1111/ijpo.12957 Last accessed September 2023.

3.

Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019. Update From the GBD 2019 Study. J Am Coll Cardiol. 2020 Dec.76(25)2982–3021. Doi: 10.1016/j.jacc.2020.11.010.

4.

Halford JCG, et al. Misalignment among adolescents living with obesity, caregivers, and healthcare professionals: ACTION Teens global survey study. Pediatric Obesity.2022;17:e12957. Available at: https://onlinelibrary.wiley.com/doi/10.1111/ijpo.12957 Last accessed September 2023.

 

The information contained in this site is intended for healthcare professionals only outside of the United States of America. This site is not intended to provide medical advice and/or treatment guidance. Only a physician can determine whether a specific product is correct for a particular patient. This site is not country-specific and therefore may contain information which is not applicable to your country. Novo Nordisk accepts no liability for the accuracy, completeness or use of this information, and disclaims any liability to update the information contained on this site. By accessing this site and materials you accept this legal notice and expressly confirm your status as a healthcare professional. Any images shown on the page are a mix of models and real patients.

 

 

HQ24OB00273, June 2024